MeSH Review:
HIV-1
- A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. Lallemant, M., Jourdain, G., Le Coeur, S., Kim, S., Koetsawang, S., Comeau, A.M., Phoolcharoen, W., Essex, M., McIntosh, K., Vithayasai, V. N. Engl. J. Med. (2000)
- Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., Landau, N.R. Cell (2003)
- Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., Landau, N.R. Cell (1996)
- Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. Imagawa, D.T., Lee, M.H., Wolinsky, S.M., Sano, K., Morales, F., Kwok, S., Sninsky, J.J., Nishanian, P.G., Giorgi, J., Fahey, J.L. N. Engl. J. Med. (1989)
- Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Gamble, T.R., Vajdos, F.F., Yoo, S., Worthylake, D.K., Houseweart, M., Sundquist, W.I., Hill, C.P. Cell (1996)
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I., Littman, D.R. Nature (1998)
- HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A. Science (1996)
- Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. Cui, Y.H., Le, Y., Gong, W., Proost, P., Van Damme, J., Murphy, W.J., Wang, J.M. J. Immunol. (2002)
- Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha. Khanna, K.V., Yu, X.F., Ford, D.H., Ratner, L., Hildreth, J.K., Markham, R.B. J. Immunol. (2000)
- Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. Lucas, G.M., Gebo, K.A., Chaisson, R.E., Moore, R.D. AIDS (2002)
- GP120: Target for Neutralizing HIV-1 Antibodies. Pantophlet, R., Burton, D.R. Annu. Rev. Immunol. (2006)
- Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Berger, E.A., Murphy, P.M., Farber, J.M. Annu. Rev. Immunol. (1999)
- And the noise played on: stochastic gene expression and HIV-1 infection. Blake, W.J., Collins, J.J. Cell (2005)
- Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Yedavalli, V.S., Neuveut, C., Chi, Y.H., Kleiman, L., Jeang, K.T. Cell (2004)
- The effects on survival of early treatment of human immunodeficiency virus infection. Graham, N.M., Zeger, S.L., Park, L.P., Vermund, S.H., Detels, R., Rinaldo, C.R., Phair, J.P. N. Engl. J. Med. (1992)
- Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. Eron, J.J., Benoit, S.L., Jemsek, J., MacArthur, R.D., Santana, J., Quinn, J.B., Kuritzkes, D.R., Fallon, M.A., Rubin, M. N. Engl. J. Med. (1995)
- Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. Luzuriaga, K., Bryson, Y., Krogstad, P., Robinson, J., Stechenberg, B., Lamson, M., Cort, S., Sullivan, J.L. N. Engl. J. Med. (1997)
- A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. Markowitz, M., Saag, M., Powderly, W.G., Hurley, A.M., Hsu, A., Valdes, J.M., Henry, D., Sattler, F., La Marca, A., Leonard, J.M. N. Engl. J. Med. (1995)
- Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. Staszewski, S., Morales-Ramirez, J., Tashima, K.T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D.F., Farina, D., Manion, D.J., Ruiz, N.M. N. Engl. J. Med. (1999)
- A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction. Braddock, M., Thorburn, A.M., Chambers, A., Elliott, G.D., Anderson, G.J., Kingsman, A.J., Kingsman, S.M. Cell (1990)
- TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Berkhout, B., Gatignol, A., Rabson, A.B., Jeang, K.T. Cell (1990)
- Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Bogerd, H.P., Fridell, R.A., Madore, S., Cullen, B.R. Cell (1995)
- Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Sperling, R.S., Shapiro, D.E., Coombs, R.W., Todd, J.A., Herman, S.A., McSherry, G.D., O'Sullivan, M.J., Van Dyke, R.B., Jimenez, E., Rouzioux, C., Flynn, P.M., Sullivan, J.L. N. Engl. J. Med. (1996)
- Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Kinoshita, S., Chen, B.K., Kaneshima, H., Nolan, G.P. Cell (1998)
- The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu, L., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard, C., Sodroski, J. Cell (1996)
- A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, S.C., Parmentier, M., Collman, R.G., Doms, R.W. Cell (1996)
- Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. Zhang, H., Dornadula, G., Beumont, M., Livornese, L., Van Uitert, B., Henning, K., Pomerantz, R.J. N. Engl. J. Med. (1998)
- DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Geijtenbeek, T.B., Kwon, D.S., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C., Middel, J., Cornelissen, I.L., Nottet, H.S., KewalRamani, V.N., Littman, D.R., Figdor, C.G., van Kooyk, Y. Cell (2000)
- Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Farzan, M., Mirzabekov, T., Kolchinsky, P., Wyatt, R., Cayabyab, M., Gerard, N.P., Gerard, C., Sodroski, J., Choe, H. Cell (1999)
- A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H., Jones, K.A. Cell (1998)
- In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Scarlatti, G., Tresoldi, E., Björndal, A., Fredriksson, R., Colognesi, C., Deng, H.K., Malnati, M.S., Plebani, A., Siccardi, A.G., Littman, D.R., Fenyö, E.M., Lusso, P. Nat. Med. (1997)
- Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group. Alter, H.J., Epstein, J.S., Swenson, S.G., VanRaden, M.J., Ward, J.W., Kaslow, R.A., Menitove, J.E., Klein, H.G., Sandler, S.G., Sayers, M.H. N. Engl. J. Med. (1990)
- Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. Daar, E.S., Moudgil, T., Meyer, R.D., Ho, D.D. N. Engl. J. Med. (1991)
- Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Cafaro, A., Caputo, A., Fracasso, C., Maggiorella, M.T., Goletti, D., Baroncelli, S., Pace, M., Sernicola, L., Koanga-Mogtomo, M.L., Betti, M., Borsetti, A., Belli, R., Akerblom, L., Corrias, F., Buttò, S., Heeney, J., Verani, P., Titti, F., Ensoli, B. Nat. Med. (1999)
- Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Lubeck, M.D., Natuk, R., Myagkikh, M., Kalyan, N., Aldrich, K., Sinangil, F., Alipanah, S., Murthy, S.C., Chanda, P.K., Nigida, S.M., Markham, P.D., Zolla-Pazner, S., Steimer, K., Wade, M., Reitz, M.S., Arthur, L.O., Mizutani, S., Davis, A., Hung, P.P., Gallo, R.C., Eichberg, J., Robert-Guroff, M. Nat. Med. (1997)
- False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. Kleinman, S., Busch, M.P., Hall, L., Thomson, R., Glynn, S., Gallahan, D., Ownby, H.E., Williams, A.E. JAMA (1998)